Endocrine Therapy in Breast Cancer: Improving Clinical Benefits
Most breast cancers express the estrogen and/or progesterone hormone receptors, which fuel tumor growth upon engagement with their respective...
Most breast cancers express the estrogen and/or progesterone hormone receptors, which fuel tumor growth upon engagement with their respective...
Accounting for less than 1 percent of all newly diagnosed cancers in the United States each year, sarcomas are...
Twenty-three pairs of chromosomes make up the human genome of normal cells. But in 1965, researchers observed that in...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
Surrounding a tumor is a vast network of blood vessels, immune cells, proteins, and even bacteria, all of which...
On December 23, 1971, when President Richard Nixon signed the National Cancer Act of 1971 into law, cancer was considered a death sentence. Only 42 percent of those diagnosed with cancer survived five years past diagnosis,...
Every cell in the human body contains about 300 million base pairs of double-stranded DNA that contribute to a...
“If our patients are diverse, why are clinical trials so white?” Vanessa Sheppard, PhD, invoked this quote from author and...
Due to advances in screening and treatment, the survival rate for patients with breast cancer has increased in recent decades. However, this progress...
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...